compounded tirzepatide programs with licensed provider oversight (GLP-1/GIP) Tirzepatide Oral | Starts at
Description
Preservative efficacy: Many compounded tirzepatide formulations use benzyl alcohol as a preservative
Mass Spectrometry confirms molecular identity by mass
The typical formulation includes 17mg/mL tirzepatide with 2mg/mL niacinamide in 4mL vials, though concentrations vary
Given that several further dual agonists are coming closer to becoming licenced, such as mazdutide and survodutide, with many more in development [15], combining licenced dual agonists with developing mono-agonists may be a faster way to develop effective treatments achieving triple agonism
Carly A
